6:21 PM
 | 
Mar 31, 2008
 |  BC Extra  |  Company News

Japan approves Naglazyme

The Japanese Ministry of Health, Labor and Welfare (MHLW) approved Naglazyme galsulfase from BioMarin (NASDAQ:BMRN; SWX:BMRN)...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >